{
    "nct_id": "NCT04495751",
    "official_title": "FOCUS - Pilot Study of Muscadine Grape Extract to Improve Fatigue Among Older Adult Cancer Survivors",
    "inclusion_criteria": "* Self-reported history of cancer diagnosed > 12 months prior to enrollment excluding non-melanoma skin cancer with no evidence of disease at enrollment.\n* Eligible solid tumor cancer types include Stage 1-3 breast, lung, head and neck, colorectal, anal, prostate, melanoma, bladder/ureteral, esophageal, gastric, pancreatic, kidney, liver/biliary, uterine, cervical, ovarian, sarcoma. (superficial disease and in situ disease only is excluded)\n* Eligible hematologic malignancies include lymphoma any subtype any stage in remission, multiple myeloma in remission, leukemia any subtype in remission.\n* Eligible prior cancer treatment modalities include surgery, radiation, chemotherapy, hormonal therapies, immunotherapy, biologic therapies.\n* All anti-cancer therapy completed > 12 months prior to enrollment\n* Age 65 years and older\n* Presence of self-reported fatigue defined by a response of \"somewhat, quite a bit or very much\" to the screening question \"During the past seven days, did you feel fatigued: Not at all, a little bit, somewhat, quite a bit, very much?\"\n* Ability to walk without requiring assistance from another individual (use of cane or walker acceptable)\n* Normal organ and marrow function as defined below:\n\n  * leukocytes >3,000/mcL\n  * absolute neutrophil count >1,500/mcL\n  * platelets >100,000/mcL\n  * total bilirubin within normal institutional limits\n  * AST(SGOT)/ALT(SGPT) <2.5 X institutional upper limit of normal\n  * creatinine clearance >30 mL/min\n* Ability to understand and the willingness to sign an IRB-approved informed consent document (either directly or via a legally authorized representative).\nHealthy volunteers allowed\nMust have minimum age of 65 Years",
    "exclusion_criteria": "* Active malignancy or on-going cancer treatment including oral anti-estrogen therapy, immunotherapy, biologic therapy.\n* Men receiving androgen deprivation therapy\n* Use of Coumadin or Warfarin (other blood thinners are acceptable)\n* Symptomatic congestive heart failure\n* Lung disease requiring oxygen\n* End stage renal disease requiring dialysis\n* Inability to swallow capsules\n* Chronic nausea or diarrhea defined by a frequency of â‰¥ once per week\n* Hemoglobin <10 g/dl\n* Diagnosis of dementia\n* Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Known untreated hypothyroidism\n* Allergy to muscadine grapes or muscadine grape preparations",
    "miscellaneous_criteria": ""
}